| C09BX02 |
bisoprolol, perindopril |
Prestilol |
Film coated tablet |
5 mg/ 10 mg |
|
30 |
Les Laboratoires Servier, Франция |
1 |
tabl |
- |
14.24 |
0.27466 |
8.24 |
50% |
4.12 |
I20.8-при пациенти с анамнеза за миокарден инфаркт и/или реваскуларизация |
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I50.0,I50.1 |
НСР-15487/26.04.2018; НСР-17987/21.02.2019;НСР-17972/21.02.2019 |
02.04.2019 |
|
|
Активен |
9181 |
| C09BX02 |
bisoprolol, perindopril |
Prestilol |
Film coated tablet |
10 mg/ 5 mg |
|
30 |
Les Laboratoires Servier, Франция |
1 |
tabl |
- |
18.66 |
0.19883 |
5.96 |
50% |
2.98 |
I20.8-при пациенти с анамнеза за миокарден инфаркт и/или реваскуларизация |
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I50.0,I50.1 |
НСР-15487/26.04.2018; НСР-17989/21.02.2019;НСР-17972/21.02.2019 |
02.04.2019 |
|
|
Активен |
9180 |
| C09BX02 |
bisoprolol, perindopril |
Prestilol |
Film coated tablet |
5 mg/5 mg |
|
30 |
Les Laboratoires Servier, Франция |
1 |
tabl |
- |
14.24 |
0.15783 |
4.73 |
50% |
2.36 |
I20.8-при пациенти с анамнеза за миокарден инфаркт и/или реваскуларизация |
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.8,I50.0,I50.1 |
НСР-15487/26.04.2018; НСР-17990/21.02.2019;НСР-17972/21.02.2019 |
02.04.2019 |
|
|
Активен |
9182 |
| C09CA01 |
Losartan |
C09CA01 Losartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA01 |
Losartan |
Hypertonic |
Film coated tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
50 |
mg |
- |
6.8 |
0.11339 |
3.4 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11892/06.03.2017; НСР-15676/17.05.2018; НСР-16086/05.07.2018 |
02.08.2018 |
|
|
Заличен |
261 |
| C09CA01 |
Losartan |
Hypertonic |
Film coated tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
50 |
mg |
- |
12.13 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦPP-580/04,05,2012.; НСР-8073/12.02.2016. |
02.03.2016 |
08.09.2012 |
|
Заличен |
261 |
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
100 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
- |
6.35 |
0.11339 |
6.35 |
25% |
1.59 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 70/ 19.04.2010; КЦРР-914/04.07.2012 г.; КЦРР-1168/08.08.2012 г.; Протокол 142/05.11.2015; НСР-8241/22.02.2016 |
02.04.2016 |
08.09.2012 |
|
Активен |
1497 |
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
50 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
- |
4.12 |
0.11339 |
3.18 |
25% |
0.79 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 53/ 24.02.2010; № 67/ 08.04.2010; КЦРР-914/04.07.2012 г.; НСР-7067/09.09.2015 |
02.04.2016 |
08.09.2012 |
|
Активен |
1285 |
| C09CA01 |
Losartan |
Losartan Genericon |
Film coated tablet |
50 |
mg |
30 |
Genericon Pharma GmbH, Австрия |
50 |
mg |
- |
11.27 |
0.245 |
7.35 |
25% |
1.84 |
|
I10,I11,I12,I13 |
№ 190/ 22.08.2011; КЦРР-1679/20.11.2012. |
20.07.2012 |
08.09.2012 |
|
Заличен |
1070 |
| C09CA01 |
Losartan |
Losartan Potassium Aurobindo |
Film coated tablet |
50 |
mg |
28 |
Aurobindo Pharma (Malta) Limited, Малта |
50 |
mg |
- |
7.96 |
0.11339 |
3.18 |
25% |
0.79 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-6160/08.05.2015; НСР-13417/04.08.2017; НСР-19098/27.06.2019 |
02.08.2019 |
|
|
Заличен |
3929 |
| C09CA01 |
Losartan |
Lotar |
Film coated tablet |
100 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
50 |
mg |
- |
12.48 |
0.11339 |
6.8 |
25% |
1.7 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-902/28.06.2012 г.; НСР-2619/03.02.2014; НСР-6091/23.04.2015. |
02.04.2016 |
08.09.2012 |
|
Активен |
3827 |
| C09CA01 |
Losartan |
Lotar |
Film coated tablet |
50 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
50 |
mg |
- |
8.74 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-903/28.06.2012 г.; НСР-6398/12.06.2015. |
02.07.2015 |
08.09.2012 |
|
Заличен |
1111 |
| C09CA01 |
Losartan |
Lozap 50 |
Film coated tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
50 |
mg |
- |
3.52 |
0.11339 |
3.4 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2674/20.03.2013 г. |
02.04.2016 |
08.09.2012 |
|
Активен |
1389 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
- |
7.37 |
0.11339 |
3.4 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-3552/16.05.2014.; НСР-6775/23.07.2015; НСР-14272/26.10.2017; НСР-19253/18.07.2019 |
02.09.2019 |
|
|
Активен |
2811 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
- |
7.39 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 92/23.06.2010; КЦРР-710/05.06.2012 г.; НСР-1225/23.09.2013; КЦРР-2652/20.03.2013 и КП-248/12.11.2013; НСР-3553/16.05.2014 |
02.06.2014 |
|
|
Заличен |
2811 |
| C09CA01 |
Losartan |
Zatan |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
50 |
mg |
- |
3.52 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-2910/05.03.2014; HCP-5715/26.02.2015. |
16.03.2015 |
|
|
Заличен |
2600 |
| C09CA01 |
Losartan |
Zatan |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
50 |
mg |
- |
3.52 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1578/05.11.2012 г; НСР-2044/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2600 |
| C09CA01 |
Losartan 100% |
C09CA01 Losartan 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
100 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
5.35 |
- |
0.09554 |
5.35 |
100% |
5.35 |
|
I10 |
HCP-8874/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1497 |
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
50 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
3.47 |
- |
0.09554 |
2.68 |
100% |
2.68 |
|
I10 |
HCP-8872/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1285 |
| C09CA01 |
Losartan |
Losartan Potassium Aurobindo |
Film coated tablet |
50 |
mg |
28 |
Aurobindo Pharma (Malta) Limited, Малта |
50 |
mg |
6.71 |
- |
0.09554 |
2.68 |
100% |
2.68 |
|
I10 |
HCP-8877/13.04.2016; НСР-13417/04.08.2017; НСР-19098/27.06.2019 |
02.08.2019 |
|
|
Заличен |
3929 |
| C09CA01 |
Losartan |
Lotar |
Film coated tablet |
100 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
50 |
mg |
10.51 |
- |
0.09554 |
5.73 |
100% |
5.73 |
|
I10 |
HCP-8875/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3827 |
| C09CA01 |
Losartan |
Lozap 50 |
Film coated tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
50 |
mg |
2.96 |
- |
0.09554 |
2.87 |
100% |
2.87 |
|
I10 |
HCP-8873/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1389 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
6.2 |
- |
0.09554 |
2.87 |
100% |
2.87 |
|
I10 |
HCP-8876/13.04.2016.; НСР-14272/26.10.2017.; НСР-19253/18.07.2019 |
02.09.2019 |
|
|
Активен |
2811 |
| C09CA02 |
Eprosartan |
C09CA02 Eprosartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|